Access Infinity aims to streamline decision-making and strategy development across a pharma product’s life cycle
Published: 2023-05-20 | Author: VisionariesNetwork Team
The pharmaceutical industry is indeed going through a phase of great change, mainly due to increasing demand for better efficiency and effectiveness in developing and distributing medicines. This is what several factors bring about: the escalations of cost in healthcare, the need for personalized medicine, and the enhanced importance of regulatory compliance. In such a scenario, pharmaceutical companies have no choice but to rethink their century-old practices and implement innovative strategies to compete in the market.
One of the significant reasons for this shift is the pressure to reduce the time and cost involved in bringing new drugs into the market. It is estimated that the time needed to bring drugs to the market exceeds ten years, which is also expensive and runs into billions of dollars.
In this way, companies have to make their operations faster and more efficient. This has led to the adaptation of sophisticated technologies such as artificial intelligence machine learning, and big data analytics as R&D processes can be greatly improved using these technologies. Companies can quickly identify potential drug candidates and optimize the design of clinical trials, enhancing recruitment as well as retention of patients.
The company Access Infinity is a consultancy firm that initially began offering services in 2014 for pharmaceutical firms to find their way in the path that will propel them forward into new challenges. It started by providing the strategies and means of attaining market access as well as its appropriate pricing for pharma businesses. As the company progressed, so did its offerings; over the years, Access Infinity expanded for innovative digital tools-from Access Hub, and Evidence Hub, to Nuro-to aid decisions and strategy development at every stage of a product's life cycle.
The heart of Access Infinity's approach is built upon a foundation of collaboration, excellence, and care. The company values are encapsulated in this trinity, guiding it in work with clients and employees in the same manner. Whether it's culture-building, hard work dedicated to excellence, or being really concerned about the well-being of both its employees and clients, Access Infinity has only the best of results in store.
The innovation that Access Infinity introduces to the market, in relation to a powerful digital platform, involves eliciting data-based insights on everything from pricing to clinical trials to HTA, or Health Technology Assessment. Users can access all the information in one place, compare and contrast the data points side by side, and export insights in a range of formats. It is a very potent tool meant to support pharma companies in making more informed decisions and ultimately in staying ahead of their competition.
Yet another addition to the Access Infinity portfolio is Evidence Hub, the continuously updated library of value messages and evidence. Through that channel, users collect and catalog all the support evidence of an asset's value story: getting automatic updates and a living evidence base for your asset. Such innovative solution helps streamline processes in evidence management by pharma companies while they make more informed choices about their products.
As one of the leading market access consultancy firms, Infinity has an exceptionally good experience working with its customers to deliver over 1,500 projects and support over 250 brands that have entered the market. The firm extends its reach across three continents and currently engages more than 40 market access consultants in over 40 countries. The strong network of this firm therefore provides it with unmatched insights and support supplied to the clients.
Not only does Access Infinity's team consist of experts and global reach, but also great skills and attention to detail. The company conducts interviews in-house with a talented multi-lingual team and can, therefore, provide an accurate transcript and soundbites that are useful for decision-making purposes for the clients.
Shrinivas Rao Mukku, Founding Director
Shri has over 14 years of industry experience, working with firms like Merck and Lundbeck, Access Partnership, and Double Helix. Shri has a PhD from the Asian Institute of Technology and an MPhil from the University of Cambridge.
“We believe in recognizing achievements, big or small, and fostering a culture of celebration that motivates our team to progress together as a collective.”
Browse our most recent publications
